Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 267-636-0 | CAS number: 67905-17-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
- Toxic effect type:
- dose-dependent
Effects on fertility
Description of key information
Reproductive toxicity study
Based on the data available from different studies, the No Observed Adverse Effect Level (NOAEL) for test material was considered to be 1000 mg/kg/day for reproductive toxicity, when rodents were treated with test material orally by gavage. Thus, comparing this value with the criteria of CLP regulation test material is not likely to classify as reproductive toxicant.
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- Experimental data from various test chemicals
- Justification for type of information:
- Weight of evidence approach based on the data of the read-across chemicals.
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- other: As mentioned below
- Principles of method if other than guideline:
- WoE report is based on 3 reproductive toxicity studies i.e. WoE-2, WoE-3 and WoE-4.
- GLP compliance:
- not specified
- Limit test:
- no
- Justification for study design:
- No data
- Species:
- rat
- Strain:
- other: 2. Crj: CD(SD) 3. Wistar 4. HanBrl:WIST (SPF)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 2. No Data Available
3. No data available
4. No data available - Route of administration:
- oral: gavage
- Type of inhalation exposure (if applicable):
- not specified
- Vehicle:
- other: 2. 0.5% w/v Methylcellulose aqueous solution (suspended) 3. 1% carboxymethylcellulose in water 4. bi-distilled water containing 1% carboxymethylcellulose
- Details on exposure:
- 2. VEHICLE
- Justification for use and choice of vehicle (if other than water): 0.5 % Methylcellulose solution was used because the test chemical was insoluble in water.
- Concentration in vehicle: 5 mL/kg
3. - Concentration in vehicle: 0, 100, 300 and 1000 mg/kg bw/day (0, 94, 282 or 940 mg active dye/kg bw/day)
- Amount of vehicle (if gavage): 10 ml/kg
4. PREPARATION OF DOSING SOLUTIONS: The test substance mixed in bi-destilled water containing 1% carboxymethylcellulose
VEHICLE
- Justification for use and choice of vehicle (if other than water): The test substance mixed in bi-destilled water containing 1% carboxymethylcellulose
- Concentration in vehicle :0, 100, 300 and 1000 mg/kg bw/day (0, 86, 258, and 861 mg active dye/kg bw/day)
- Amount of vehicle (if gavage): 10 ml/kg bw - Details on mating procedure:
- 2. .- M/F ratio per cage: 12 pairs/dose
- Length of cohabitation: Male and female were allowed to live in a male cage one to one.
- Proof of pregnancy: [vaginal plug / sperm in vaginal smear] referred to as [day 0 / day 1] of pregnancy
3. No data available
4. No data available - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- 2. The prepared solution was confirmed by UV-visible absorbance method
- Duration of treatment / exposure:
- 2. Males: 42 Days
Females: 41-45 days(from 14 days before mating to day 4 of lactation)
3. 12 days (6-17 of gestation period)
4. 14 days (from day 6 (implantation) through to day 20 post coitum ) - Frequency of treatment:
- Daily
- Details on study schedule:
- 2. No Data Available
3. A prenatal developmental study was conducted on female Wistar rats.
4. No data available - Remarks:
- 2. 0 (Control), 0 (Recovery), 40 (Low Dose), 200 (Mid-Dose), 1000 (High dose), 1000 (Recovery) mg/kg/day
3. 0, 100, 300 and 1000 mg/kg bw/day (0, 94, 282 or 940 mg active dye/kg bw/day)
4. 0, 100, 300 and 1000 mg/kg bw/day (0, 86, 258, and 861 mg active dye/kg bw/day) - No. of animals per sex per dose:
- 2. Males: 12 animals/group/sex (5 animals for recovery group)
Females: 12 animals/group/sex (5 animals for recovery group)
3. Total number of animals-88
0 mg /kg bw/day -22 female rats
94 mg /kg bw/day -22 female rats
282 mg /kg bw/day -22 female rats
940 mg /kg bw/day-22 female rats
4. Total:88
0 mg/kg bw/day:22
100mg/kg bw/day:22
300mg/kg bw/day:22
1000 mg/kg bw/day:22 - Control animals:
- yes, concurrent vehicle
- Details on study design:
- 2. No Data Available
3. No data
4. No data available - Positive control:
- No Data Available
- Parental animals: Observations and examinations:
- 2. CAGE SIDE OBSERVATIONS: Yes
- Time schedule: No Data Available
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: No Data Available
BODY WEIGHT: Yes
- Time schedule for examinations: No Data Available
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): Yes
OTHER: No Data Available
3. Parental animal: observation and examination- Clinical sign, body weight and food intake was observed.
Histopathology- About one half of the foetuses were examined for soft tissue anomalies whereas remaining foetuses were examined for skeletal anomalies following alizarin red staining.
4. CAGE SIDE OBSERVATIONS: yes
DETAILED CLINICAL OBSERVATIONS: Yes
Time schedule: twice daily.
BODY WEIGHT: Yes
Time schedule for examinations: daily
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): Yes on 3-day intervals
Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes / No / No data: No data available
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No data
Time schedule for examinations: - Oestrous cyclicity (parental animals):
- 2. Yes, Oestrus cycle was examined.
3. No data
4. No data available - Sperm parameters (parental animals):
- 2. Parameters examined in [P] male parental generations: testis weight, epididymis weight
3. No data
4. No data available - Litter observations:
- 2. Yes, The effect of the test chemical was observed on the litter parameters.
3. Foetuses were sexed and weighed.
4. No data available - Postmortem examinations (parental animals):
- 2. SACRIFICE
- Male animals: All surviving animals.
- Maternal animals: All surviving animals
GROSS NECROPSY
- Yes, gross necropsy was performed on all the organs in abdomen, viscera and reproductive organs.
HISTOPATHOLOGY / ORGAN WEIGHTS: Yes, Organs weights and Histopathology was performed.
3. Embryonic resorptions and implantation sites was observed.
4. SACRIFICE: On day 21 post-coitum, the dams were sacrificed
Male animals: All surviving animals [describe when, e.g. as soon as possible after the last litters in each generation were produced.]: No data
Maternal animals: yes (subjected to macroscopic examination.)
GROSS NECROPSY:
HISTOPATHOLOGY / ORGAN WEIGHTS
The tissues indicated in Table [#] were prepared for microscopic examination and weighed, respectively.: macroscopic examination was performed - Postmortem examinations (offspring):
- 2. No Data Available
3. Foetuses were observed externely.
4. Postmortem examinations (offspring)
SACRIFICE
- The F1 offspring not selected as parental animals and all F2 offspring were sacrificed at [#?] days of age.
- These animals were subjected to postmortem examinations (macroscopic and/or microscopic examination) as follows: The foetuses were removed by Caesarean section, sexed, weighed, examined for gross external abnormalities, killed, and allocated to either visceral or skeletal (about one half of the foetuses for each examination). - Statistics:
- 2. No Data Available
3. No data
4. No data available - Reproductive indices:
- 2. Gestational Index, estrous cycle examination, Copulation Index, Copulation interval, fertility index, gestation period, no of corpora lutea, number of implantations, implantation index, delivery index, nursing behaviour.
3. No data
4. No data available - Offspring viability indices:
- 2. Pup Viability Index
3. No data
4. No data available - Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- 2. effects observed, treatment-related - Test item coloured fecal matter in both male and female animals was observed in both the dose groups.
3. effects observed, non-treatment-related - Discoloured faeces were observed at 940 mg/kg bw/day.
4. no effects observed - Clinical signs included darker faeces (all treated groups, from day 7-21 post coitum), and discolouration of skin, eyes and bedding (generally only in the 1000mg/kg bw dose group) - Dermal irritation (if dermal study):
- not specified
- Mortality:
- no mortality observed
- Description (incidence):
- 2. no mortality observed - No Mortality was observed in all animals in either of the dose groups.
3. no mortality observed
4. no mortality observed - No mortalities occurred. - Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- 2. no effects observed - No abnormal effects were observed in body weight changes in males or females due to the test chemical administration.
3. not specified
4. effects observed, treatment-related - The mean body weight gain was slightly decreased and the corrected body weight gain (corrected for gravid uterus weight) was marginally lower in 1000mg/kg bw /day dose females compared to control females - Food consumption and compound intake (if feeding study):
- no effects observed
- Description (incidence and severity):
- 2. no effects observed - No abnormal effects were observed in feed consumption patterns in males or females due to the test chemical administration.
3. not specified
4. no effects observed - Food consumption was similar in treated and control groups. - Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- no effects observed
- Description (incidence and severity):
- 2. no effects observed - No abnormal effects were observed in hematological parameters in males or females due to the test chemical administration.
3. not specified
4. not specified - Clinical biochemistry findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- 2. effects observed, non-treatment-related - Significant decrease in Albumin content, Total Protein, and significant increase in α2-Globulin (%) in males of 1000 mg/kg bw was observed. No effects in females were observed. However, these effects were considered to be toxicolgically insignificant since, therse effects were observed to be reversed in the recovery group.
3. not specified
4. not specified - Urinalysis findings:
- effects observed, treatment-related
- Description (incidence and severity):
- 2. effects observed, treatment-related - Abnormal coloration in the urine was observed in males and females at 200 mg/kg bw and 1000 mg/kg bw dose groups. This coloration was attributed to the test chemical or a metabolite of the test chemical.
3. not specified
4. not specified - Behaviour (functional findings):
- no effects observed
- Description (incidence and severity):
- 2. no effects observed - No effect of the test chemical was observed on the grip strength, locomotor activity and other functional observation battery parameters in either sex at all the dose groups.
3. not specified
4. not specified - Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- 2. no effects observed - No histopathological abnormalities were observed in any animals of either sex and at all the dose levels, including the high dose recovery groups.
3. not specified
4. not specified - Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
- Reproductive function: oestrous cycle:
- no effects observed
- Description (incidence and severity):
- 2. no effects observed - No effects on the estrous cyclicity due to the test chemical was observed at any dose groups.
3. not specified
4. not specified - Reproductive function: sperm measures:
- no effects observed
- Description (incidence and severity):
- 2. no effects observed
3. not specified
4. not specified - Reproductive performance:
- no effects observed
- Description (incidence and severity):
- 2. no effects observed - No effects on the reproductive performance due to the test chemical was observed at any dose groups.
3. no effects observed - In the group who received 100 mg /kg bw/day one female had only embryonic resorptions and in the highest dose group two females were not pregnant, one female had only empty implantation sites and a further one only embryonic resorptions at Caesarean section. These findings were considered to be incidental as a dose relation was missing.
4. no effects observed - One low-dose female was not pregnant. The incidence of pre-implantation loss was slightly higher (statistically significant) in the high-dose group; this difference was considered as being incidental by the study authors because pre-implantation loss mainly occurred prior to onset of treatment. Post-implantation loss and number of foetuses per dam was not affected. - Dose descriptor:
- NOAEL
- Remarks:
- 2
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- clinical signs
- mortality
- body weight and weight gain
- food consumption and compound intake
- haematology
- clinical biochemistry
- urinalysis
- organ weights and organ / body weight ratios
- gross pathology
- histopathology: non-neoplastic
- reproductive function (oestrous cycle)
- reproductive function (sperm measures)
- reproductive performance
- Remarks on result:
- other: No effects observed
- Dose descriptor:
- NOAEL
- Remarks:
- 3
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- clinical signs
- mortality
- reproductive performance
- Remarks on result:
- other: overall no effects on reproductive performance was observed
- Remarks:
- Maternal toxicity was not observed at all dose level.
- Dose descriptor:
- NOAEL
- Remarks:
- 4
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- reproductive performance
- Remarks on result:
- other: overall no effects on reproductive parameters
- Dose descriptor:
- NOAEL
- Remarks:
- 4
- Effect level:
- 300 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- clinical signs
- mortality
- body weight and weight gain
- food consumption and compound intake
- gross pathology
- Remarks on result:
- other: maternal toxicity
- Critical effects observed:
- not specified
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- 2. no effects observed
3. no effects observed - No significannt change were observed in treated group compare to control group.
4. not specified - Dermal irritation (if dermal study):
- not specified
- Mortality / viability:
- no mortality observed
- Description (incidence and severity):
- 2. no mortality observed
3. not specified
4. not specified - Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- 2. no effects observed
3. no effects observed - No significannt change were observed in treated group compare to control group.
4. no effects observed - No effects on foetal weight were observed. - Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- no effects observed
- Description (incidence and severity):
- 2. no effects observed
3. not specified
4. not specified - Anogenital distance (AGD):
- not specified
- Nipple retention in male pups:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- 2. no effects observed
3. no effects observed - No significant change was observed on external soft tissue and skeletal anomalies based in treated group compare to control group .
4. no effects observed - Incidences of external, visceral and skeletal findings were similar for control and treated groups. - Histopathological findings:
- no effects observed
- Description (incidence and severity):
- 2. no effects observed
3. no effects observed
4. not specified - Other effects:
- no effects observed
- Description (incidence and severity):
- 2. no effects observed - No effects were observed on number of pups delivered, number of live pups, live birth index, viability index and sex ratio on day 0 and day 4 at any dose groups.
3. not specified
4. not specified - Behaviour (functional findings):
- not specified
- Developmental immunotoxicity:
- not specified
- Dose descriptor:
- NOAEL
- Remarks:
- 2
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- viability
- sexual maturation
- clinical signs
- mortality
- body weight and weight gain
- gross pathology
- histopathology: non-neoplastic
- other: number of pups delivered, number of live pups, live birth index, viability index and sex ratio on day 0 and day 4
- Remarks on result:
- other: No effects observed
- Dose descriptor:
- NOAEL
- Remarks:
- 3
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- clinical signs
- body weight and weight gain
- gross pathology
- Remarks on result:
- other: overall no developmental toxic effects observed
- Dose descriptor:
- NOAEL
- Remarks:
- 4
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- viability
- body weight and weight gain
- gross pathology
- Remarks on result:
- other: overall no effects on developmental parameters were observed
- Critical effects observed:
- not specified
- Reproductive effects observed:
- not specified
- Conclusions:
- Based on the data available from different studies, the No Observed Adverse Effect Level (NOAEL) for test material was considered to be 1000 mg/kg/day for reproductive toxicity, when rodents were treated with test material orally by gavage. Thus, comparing this value with the criteria of CLP regulation test material is not likely to classify as reproductive toxicant.
- Executive summary:
Data available from different studies were reviewed to determine the reproductive toxicity of test chemical. The studies are as mentioned below:
In a combined repeated and reproductive toxicity study according to OECD 422 guideline, the test chemical was administered to Crl:CD (SD) male and female rats, aged 10 weeks old at the initiation of dosing. The rats were dosed at concentrations of 0, 40, 200, 1000 mg/kg/day with two reversal groups of 0 and 1000 mg/kg bw/day as control and high dose group recovery group, respectively. The vehicle used in the study was 0.5% w/v Methylcellulose aqueous suspended solution. Male animals were dosed for 42 Days, while females were dosed for 41-45 days. After the administration of the test chemical, test item colored fecal matter in both male and female animals was observed in both the dose groups. However, no mortality was observed in all animals in either of the dose groups. No abnormal effects were observed in body weight changes and feed consumption in males or females due to the test chemical administration. In hematological parameters, no abnormal effects were observed in hematological parameters in males or females due to the test chemical administration. In blood chemistry parameters, significant decrease in Albumin content, Total Protein, and significant increase in α2-Globulin (%) in males of 1000 mg/kg bw was observed. No effects in females were observed. However, these effects were considered to be toxicolgically insignificant since, these effects were observed to be reversed in the recovery group. Also, abnormal coloration in the urine was observed in males and females at 200 mg/kg bw and 1000 mg/kg bw dose groups. This coloration was attributed to the test chemical or a metabolite of the test chemical. No effect of the test chemical was observed on the grip strength, locomotor activity and other functional observation battery parameters in either sex at all the dose groups. No adverse effects were observed on any abdominal, visceral or reproductive organs / 100 grams of body weight due to the test chemical in either of the sex at any dose groups. In gross necropsy, colored aqueous content in the alimentary tract was observed in males, and in males and females both 40 mg/kg bw dose group and 200 mg/kg bw dose group, respectively. Also, mucosal discoloration of alimentary tract in males of 200 mg/kg bw was also observed. Colored aqueous content in the alimentary tract and mucosal discoloration of alimentary tract in both males and females were observed in 1000 mg/kg bw dose group. However, these effects were reversed in the recovery group doses and thus were not considered to be of toxicological significance. No histopathological abnormalities were observed in any animals of either sex and at all the dose levels, including the high dose recovery groups. No effects on the estrous cyclicity due to the test chemical were observed at any dose groups. No effects on the reproductive performance due to the test chemical were observed at any dose groups. No effects were observed on number of pups delivered, number of live pups, live birth index, viability index and sex ratio on day 0 and day 4 at any dose groups. Also, no test chemical changes were noted in the number of pups delivered, number of live pups, live birth index, viability index or sex ratio on day 0 and 4, clinical signs, body weights, external examinations, body weights or necropsy. Thus, based on all the observations and results it was concluded that the NOAEL for the test chemical was considered to be 1000 mg/kg bw.
In another Prenatal Developmental Toxicity Study, the given test chemical was exposed at the concentration of 0, 100, 300 and 1000 mg/kg bw/day (0, 94, 282 or 940 mg active dye/kg bw/day) through 6-17of gestation period by oral (gavage) to 22 females Wistar rats. The test substance (in 1% carboxymethylcellulose in water) was given daily at dose volumes of 10 ml/kg bw by oral gavage. The doses were selected on the basis of the results of a preliminary study in rats. Maternal evaluations and measurements included daily clinical signs and body weight/food intake recorded at designated intervals. The females were killed on gestation day 21, subjected to macroscopic examination, and foetuses were removed by Caesarean section. Common litter parameters were recorded and foetuses were sexed, weighed and submitted to external examination. About one half of the foetuses were also examined for soft tissue anomalies whereas remaining foetuses were examined for skeletal anomalies following alizarin red staining. There were 20 to 22 pregnant females per group. In the group who received 100 mg /kg bw/day one female had only embryonic resorptions and in the highest dose group two females were not pregnant, one female had only empty implantation sites and a further one only embryonic resorptions at Caesarean section. These findings were considered to be incidental as a dose relation was missing. No deaths were reported, and clinical signs were limited to discoloured faeces at 1000 mg/kg bw/day. No effects on litter parameters or foetal weight were observed. Foetal and litter incidences of external, soft tissue and skeletal anomalies were similar for control and treated groups. Under the condition of the study, NOAEL was considered to be 1000 mg /kg bw/day for reproductive toxicity in P0 female Wistar rats, when they were exposed with test material at the concentration of 0, 100, 300 and 1000 mg/kg bw/day through 6-17 of gestation period by oral (gavage).
Both the above studies were supported with another Prenatal Developmental Toxicity Study performed by using the given test chemical on 22 mated females per dose group HanBrl:WIST (SPF) rats at the concentration of 0, 100, 300 and 1000 mg/kg bw/day (0, 86, 258, and 861 mg active dye/kg bw/day). The test substance (in bi-distilled water containing 1% carboxymethylcellulose) was given daily at dose volumes of 10 ml/kg bw by oral gavage. Mortality, morbidity, signs of abortion, and clinical signs and/or symptoms was checked at least twice daily. Food consumption was recorded on 3-day intervals and body weights were recorded daily. The females were sacrificed on gestation day 21, subjected to macroscopic examination. The foetuses were removed by Caesarean section, sexed, weighed, examined for gross external abnormalities, killed, and allocated to either visceral or skeletal (about one half of the foetuses for each examination). No mortalities occurred. Clinical signs included darker faeces (all treated groups, from day 7-21 post coitum), and discolouration of skin, eyes and bedding (generally only in the highdose group). The mean body weight gain was slightly decreased and the corrected body weight gain (corrected for gravid uterus weight) was marginally lower in high-dose females compared to control females. Food consumption was similar in treated and control groups. One low-dose female was not pregnant. The incidence of pre-implantation loss was slightly higher (statistically significant) in the high-dose group; this difference was considered as being incidental by the study authors because pre-implantation loss mainly occurred prior to onset of treatment. Post-implantation loss and number of foetuses per dam was not affected. At necropsy discolouration of intestinal contents, kidneys, fatty tissues, intrauterine fluids and foetuses was noted in all high-dose dams. No effects on litter parameters or foetal weight were observed. Incidences of external, visceral and skeletal findings were similar for control and treated groups. Under the condition of the study, the No Observed Adverse Effect Level (NOAEL) for maternal toxicity is considered to be 300 mg/kg bw/day (258 mg active dye/kg bw/day) and the NOAEL for reproductive and developmental toxicity is considered to be 1000 mg/kg bw/day (861 mg active dye/kg bw/day), when female HanBrl:WIST (SPF) rats were treated with test material orally.
Based on the data available from different studies, NOAEL for test material was considered to be 1000 mg/kg/day for reproductive toxicity, when rodents were treated with test material orally. Thus, comparing this value with the criteria of CLP regulation test material is not likely to classify as reproductive toxicant.
- Endpoint:
- screening for reproductive / developmental toxicity
- Data waiving:
- other justification
- Justification for data waiving:
- other:
- Justification for type of information:
- The study is ongoing and this information will be submitted later based on ECHA communication/decision number CCH-D-2114497522-42-01/F.
Referenceopen allclose all
3. No data
4. not specified
3. not specified
4. not specified
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- Data is Klimicsh 2 and from handbook or collection of data.
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Reproductive toxicity study
Data available from different studies were reviewed to determine the reproductive toxicity of test chemical. The studies are as mentioned below:
In a combined repeated and reproductive toxicity study according to OECD 422 guideline, the test chemical was administered to Crl:CD (SD) male and female rats, aged 10 weeks old at the initiation of dosing. The rats were dosed at concentrations of 0, 40, 200, 1000 mg/kg/day with two reversal groups of 0 and 1000 mg/kg bw/day as control and high dose group recovery group, respectively. The vehicle used in the study was 0.5% w/v Methylcellulose aqueous suspended solution. Male animals were dosed for 42 Days, while females were dosed for 41-45 days. After the administration of the test chemical, test item colored fecal matter in both male and female animals was observed in both the dose groups. However, no mortality was observed in all animals in either of the dose groups. No abnormal effects were observed in body weight changes and feed consumption in males or females due to the test chemical administration. In hematological parameters, no abnormal effects were observed in hematological parameters in males or females due to the test chemical administration. In blood chemistry parameters, significant decrease in Albumin content, Total Protein, and significant increase in α2-Globulin (%) in males of 1000 mg/kg bw was observed. No effects in females were observed. However, these effects were considered to be toxicolgically insignificant since, these effects were observed to be reversed in the recovery group. Also, abnormal coloration in the urine was observed in males and females at 200 mg/kg bw and 1000 mg/kg bw dose groups. This coloration was attributed to the test chemical or a metabolite of the test chemical. No effect of the test chemical was observed on the grip strength, locomotor activity and other functional observation battery parameters in either sex at all the dose groups. No adverse effects were observed on any abdominal, visceral or reproductive organs / 100 grams of body weight due to the test chemical in either of the sex at any dose groups. In gross necropsy, colored aqueous content in the alimentary tract was observed in males, and in males and females both 40 mg/kg bw dose group and 200 mg/kg bw dose group, respectively. Also, mucosal discoloration of alimentary tract in males of 200 mg/kg bw was also observed. Colored aqueous content in the alimentary tract and mucosal discoloration of alimentary tract in both males and females were observed in 1000 mg/kg bw dose group. However, these effects were reversed in the recovery group doses and thus were not considered to be of toxicological significance. No histopathological abnormalities were observed in any animals of either sex and at all the dose levels, including the high dose recovery groups. No effects on the estrous cyclicity due to the test chemical were observed at any dose groups. No effects on the reproductive performance due to the test chemical were observed at any dose groups. No effects were observed on number of pups delivered, number of live pups, live birth index, viability index and sex ratio on day 0 and day 4 at any dose groups. Also, no test chemical changes were noted in the number of pups delivered, number of live pups, live birth index, viability index or sex ratio on day 0 and 4, clinical signs, body weights, external examinations, body weights or necropsy. Thus, based on all the observations and results it was concluded that the NOAEL for the test chemical was considered to be 1000 mg/kg bw.
In another Prenatal Developmental Toxicity Study, the given test chemical was exposed at the concentration of 0, 100, 300 and 1000 mg/kg bw/day (0, 94, 282 or 940 mg active dye/kg bw/day) through 6-17of gestation period by oral (gavage) to 22 females Wistar rats. The test substance (in 1% carboxymethylcellulose in water) was given daily at dose volumes of 10 ml/kg bw by oral gavage. The doses were selected on the basis of the results of a preliminary study in rats. Maternal evaluations and measurements included daily clinical signs and body weight/food intake recorded at designated intervals. The females were killed on gestation day 21, subjected to macroscopic examination, and foetuses were removed by Caesarean section. Common litter parameters were recorded and foetuses were sexed, weighed and submitted to external examination. About one half of the foetuses were also examined for soft tissue anomalies whereas remaining foetuses were examined for skeletal anomalies following alizarin red staining. There were 20 to 22 pregnant females per group. In the group who received 100 mg /kg bw/day one female had only embryonic resorptions and in the highest dose group two females were not pregnant, one female had only empty implantation sites and a further one only embryonic resorptions at Caesarean section. These findings were considered to be incidental as a dose relation was missing. No deaths were reported, and clinical signs were limited to discoloured faeces at 1000 mg/kg bw/day. No effects on litter parameters or foetal weight were observed. Foetal and litter incidences of external, soft tissue and skeletal anomalies were similar for control and treated groups. Under the condition of the study, NOAEL was considered to be 1000 mg /kg bw/day for reproductive toxicity in P0 female Wistar rats, when they were exposed with test material at the concentration of 0, 100, 300 and 1000 mg/kg bw/day through 6-17 of gestation period by oral (gavage).
Both the above studies were supported with another Prenatal Developmental Toxicity Study performed by using the given test chemical on 22 mated females per dose group HanBrl:WIST (SPF) rats at the concentration of 0, 100, 300 and 1000 mg/kg bw/day (0, 86, 258, and 861 mg active dye/kg bw/day). The test substance (in bi-distilled water containing 1% carboxymethylcellulose) was given daily at dose volumes of 10 ml/kg bw by oral gavage. Mortality, morbidity, signs of abortion, and clinical signs and/or symptoms was checked at least twice daily. Food consumption was recorded on 3-day intervals and body weights were recorded daily. The females were sacrificed on gestation day 21, subjected to macroscopic examination. The foetuses were removed by Caesarean section, sexed, weighed, examined for gross external abnormalities, killed, and allocated to either visceral or skeletal (about one half of the foetuses for each examination). No mortalities occurred. Clinical signs included darker faeces (all treated groups, from day 7-21 post coitum), and discolouration of skin, eyes and bedding (generally only in the highdose group). The mean body weight gain was slightly decreased and the corrected body weight gain (corrected for gravid uterus weight) was marginally lower in high-dose females compared to control females. Food consumption was similar in treated and control groups. One low-dose female was not pregnant. The incidence of pre-implantation loss was slightly higher (statistically significant) in the high-dose group; this difference was considered as being incidental by the study authors because pre-implantation loss mainly occurred prior to onset of treatment. Post-implantation loss and number of foetuses per dam was not affected. At necropsy discolouration of intestinal contents, kidneys, fatty tissues, intrauterine fluids and foetuses was noted in all high-dose dams. No effects on litter parameters or foetal weight were observed. Incidences of external, visceral and skeletal findings were similar for control and treated groups. Under the condition of the study, the No Observed Adverse Effect Level (NOAEL) for maternal toxicity is considered to be 300 mg/kg bw/day (258 mg active dye/kg bw/day) and the NOAEL for reproductive and developmental toxicity is considered to be 1000 mg/kg bw/day (861 mg active dye/kg bw/day), when female HanBrl:WIST (SPF) rats were treated with test material orally.
Based on the data available from different studies, NOAEL for test material was considered to be 1000 mg/kg/day for reproductive toxicity, when rodents were treated with test material orally. Thus, comparing this value with the criteria of CLP regulation test material is not likely to classify as reproductive toxicant.
Effects on developmental toxicity
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Comparing the NOAEL value and effects observed on rodents, with the criteria of CLP regulation the given test chemical is not likely to classify as reproductive toxicant.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.